CXCL8 and glioma: Circulating readouts that reflect myeloid trafficking complement tissue metrics; in glioma models, IL-8 neutralization enhances the efficacy of immune checkpoint blockade, supporting baseline and on-treatment IL-8 as a negative biomarker and as a targetable axis (16, 19, 72).